Literature DB >> 19948766

Effects of chemical modification on the potency, serum stability, and immunostimulatory properties of short shRNAs.

Qing Ge1, Anne Dallas, Heini Ilves, Joshua Shorenstein, Mark A Behlke, Brian H Johnston.   

Abstract

Small hairpin RNAs (shRNAs) with 19-base-pair, or shorter, stems (short shRNAs [sshRNAs]) have been found to constitute a class whose mechanism of action appears to be distinct from that of small interfering RNAs (siRNAs) or longer shRNAs. These sshRNAs can be as active as canonical siRNAs or longer shRNAs. Their activity is affected by whether the antisense strand is positioned 5' or 3' to the loop (L or R sshRNAs, respectively). Dicer seems not to be involved in the processing of sshRNAs, although the mechanism of target gene suppression by these hairpins is through Ago2-mediated mRNA cleavage. In this study, the effects of chemical modifications on the potency, serum stability, and innate immune response of sshRNAs were investigated. Deoxynucleotide substitution and 2'-O-methyl (2'-OMe) modification in the sense strand and loop did not affect silencing activity, but, unlike with siRNAs, when placed in the antisense strand these modifications were detrimental. Conjugation with bulky groups at the 5'-end of L sshRNAs or 3'-end of R sshRNAs had a negative impact on the potency. Unmodified sshRNAs in dimer form or with blunt ends were immunostimulatory. Some modifications such as 3'-end conjugation and phosphorothioate linkages on the backbone of the sshRNAs could also induce inflammatory cytokine production. However, 2'-OMe substitution of sshRNAs abrogated the innate immune response and improved the serum stability of the hairpins.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19948766      PMCID: PMC2802022          DOI: 10.1261/rna.1901810

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  63 in total

1.  Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.

Authors:  Katalin Karikó; Michael Buckstein; Houping Ni; Drew Weissman
Journal:  Immunity       Date:  2005-08       Impact factor: 31.745

2.  Synthetic shRNAs as potent RNAi triggers.

Authors:  Despina Siolas; Cara Lerner; Julja Burchard; Wei Ge; Peter S Linsley; Patrick J Paddison; Gregory J Hannon; Michele A Cleary
Journal:  Nat Biotechnol       Date:  2004-12-26       Impact factor: 54.908

Review 3.  Vector-based RNAi approaches for stable, inducible and genome-wide screens.

Authors:  Gwen D Fewell; Karin Schmitt
Journal:  Drug Discov Today       Date:  2006-09-26       Impact factor: 7.851

4.  Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA.

Authors:  Charles R Allerson; Namir Sioufi; Russell Jarres; Thazha P Prakash; Nishant Naik; Andres Berdeja; Lisa Wanders; Richard H Griffey; Eric E Swayze; Balkrishen Bhat
Journal:  J Med Chem       Date:  2005-02-24       Impact factor: 7.446

5.  RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model.

Authors:  Scott Q Harper; Patrick D Staber; Xiaohua He; Steven L Eliason; Inês H Martins; Qinwen Mao; Linda Yang; Robert M Kotin; Henry L Paulson; Beverly L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-05       Impact factor: 11.205

6.  Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo.

Authors:  Adam D Judge; Gurneet Bola; Amy C H Lee; Ian MacLachlan
Journal:  Mol Ther       Date:  2005-12-15       Impact factor: 11.454

7.  Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs.

Authors:  David V Morrissey; Jennifer A Lockridge; Lucinda Shaw; Karin Blanchard; Kristi Jensen; Wendy Breen; Kimberly Hartsough; Lynn Machemer; Susan Radka; Vasant Jadhav; Narendra Vaish; Shawn Zinnen; Chandra Vargeese; Keith Bowman; Chris S Shaffer; Lloyd B Jeffs; Adam Judge; Ian MacLachlan; Barry Polisky
Journal:  Nat Biotechnol       Date:  2005-07-24       Impact factor: 54.908

8.  Small hairpin RNAs efficiently inhibit hepatitis C IRES-mediated gene expression in human tissue culture cells and a mouse model.

Authors:  Qian Wang; Christopher H Contag; Heini Ilves; Brian H Johnston; Roger L Kaspar
Journal:  Mol Ther       Date:  2005-09       Impact factor: 11.454

9.  Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization.

Authors:  Mouldy Sioud
Journal:  J Mol Biol       Date:  2005-03-22       Impact factor: 5.469

10.  Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3' exonuclease in plasma.

Authors:  P S Eder; R J DeVine; J M Dagle; J A Walder
Journal:  Antisense Res Dev       Date:  1991
View more
  26 in total

Review 1.  Subcellular fate and off-target effects of siRNA, shRNA, and miRNA.

Authors:  Saurabh Singh; Ajit S Narang; Ram I Mahato
Journal:  Pharm Res       Date:  2011-10-28       Impact factor: 4.200

Review 2.  Lentiviral vector-mediated RNA silencing in the central nervous system.

Authors:  Thomas H Hutson; Edmund Foster; Lawrence D F Moon; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther Methods       Date:  2013-11-01       Impact factor: 2.396

3.  Minimal-length short hairpin RNAs: the relationship of structure and RNAi activity.

Authors:  Qing Ge; Heini Ilves; Anne Dallas; Pavan Kumar; Joshua Shorenstein; Sergei A Kazakov; Brian H Johnston
Journal:  RNA       Date:  2009-12-01       Impact factor: 4.942

4.  Efficient delivery of RNA interference oligonucleotides to polarized airway epithelia in vitro.

Authors:  Shyam Ramachandran; Sateesh Krishnamurthy; Ashley M Jacobi; Christine Wohlford-Lenane; Mark A Behlke; Beverly L Davidson; Paul B McCray
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-04-26       Impact factor: 5.464

Review 5.  Progress toward in vivo use of siRNAs-II.

Authors:  Garrett R Rettig; Mark A Behlke
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

Review 6.  Tuning the size, shape and structure of RNA nanoparticles for favorable cancer targeting and immunostimulation.

Authors:  Sijin Guo; Congcong Xu; Hongran Yin; Jordan Hill; Fengmei Pi; Peixuan Guo
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2019-08-27

7.  Formulated minimal-length synthetic small hairpin RNAs are potent inhibitors of hepatitis C virus in mice with humanized livers.

Authors:  Han Ma; Anne Dallas; Heini Ilves; Joshua Shorenstein; Ian MacLachlan; Klaus Klumpp; Brian H Johnston
Journal:  Gastroenterology       Date:  2013-09-27       Impact factor: 22.682

8.  8-Oxoguanosine switches modulate the activity of alkylated siRNAs by controlling steric effects in the major versus minor grooves.

Authors:  Arunkumar Kannan; Erik Fostvedt; Peter A Beal; Cynthia J Burrows
Journal:  J Am Chem Soc       Date:  2011-03-31       Impact factor: 15.419

9.  Induction of RNAi Responses by Short Left-Handed Hairpin RNAi Triggers.

Authors:  Jonathan C Hagopian; Alexander S Hamil; Arjen van den Berg; Bryan R Meade; Akiko Eguchi; Caroline Palm-Apergi; Steven F Dowdy
Journal:  Nucleic Acid Ther       Date:  2017-09-21       Impact factor: 5.486

10.  Inhibition of hepatitis C virus in chimeric mice by short synthetic hairpin RNAs: sequence analysis of surviving virus shows added selective pressure of combination therapy.

Authors:  Anne Dallas; Heini Ilves; Han Ma; Daniel J Chin; Ian Maclachlan; Klaus Klumpp; Brian H Johnston
Journal:  J Virol       Date:  2014-01-29       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.